15 Jan 2026 Diabetes Drug Metformin Shows Potential in Osteoarthritis Care Evidence from a clinical trial and long-term cohort studies suggests metformin, widely used in diabetes, may reduce knee osteoarthritis pain and lower future osteoarthritis risk
In one study, patients were able to see a reduction of 9.6 to 17.4% of their initial body weight after 68 weeks
Several markers of improved insulin sensitivity, including adiponectin, IGFBP-1, and IGFBP-2, significantly increased with one or more doses of tirzepatide
However, a lack of awareness of this issue is likely leading to both underdetection and under-reporting of malnutrition, she wrote, which may lead to less favorable patient outcomes
However, stores can run low due to a number of factors, including a genetic inability to produce sufficient amounts